Amytrx Therapeutics Inc. Jan 2024 a Series of CGF2021 LLC
Claymont, De
Amytrx Therapeutics Inc. Jan 2024 a Series of CGF2021 LLC is a venture capital fund managed by Amytrx Therapeutics Inc. Jan 2024 A Series Of Cgf2021 LLC. Its SEC Form D filing reports $455,025 raised, a $455,025 target, 11 investors, and a first sale on May 7, 2024.
Amount Raised
$455,025
Target Size
$455,025
Investors
11
Date Filed
2024-05-15
Dry powder breakdown
Est. Remaining
$189,594
Deployed
$265,431
58% deployed20 months remaining (4yr model)
Raised 100% of $455,025 target
Filing details
Fund vehicleAmytrx Therapeutics Inc. Jan 2024 a Series of CGF2021 LLC
IndustryVenture Capital Fund
Address2093 PHILADELPHIA PIKE, CLAYMONT, DE
Phone(360) 946-0604
Accession #0002023260-24-000001
Related personsView on SEC EDGAR ↗